About 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium
2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium (PubChem CID 146012344) has the molecular formula C21H25N6O2+
and a molecular weight of 393.47 g/mol. Its IUPAC name is 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium.
Molecular Properties
| Compound Name | 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium |
| PubChem CID | 146012344 |
| Molecular Formula | C21H25N6O2+ |
| Molecular Weight | 393.47 g/mol |
| Exact Mass | 393.20 |
| IUPAC Name | 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium |
| SMILES | CCn1cnc2cc(-c3cc(OCC[NH+](C)C)c(C(N)=O)c4[nH]cnc34)ccc21 |
| InChI | InChI=1S/C21H24N6O2/c1-4-27-12-25-15-9-13(5-6-16(15)27)14-10-17(29-8-7-26(2)3)18(21(22)28)20-19(14)23-11-24-20/h5-6,9-12H,4,7-8H2,1-3H3,(H2,22,28)(H,23,24)/p+1 |
| InChIKey | APQDNQILCACUFF-UHFFFAOYSA-O |
| XLogP | 1.22 |
| TPSA | 103.26 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 393.47 |
| LogP ≤ 5 | 1.22 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Analyze 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium?
The IUPAC name of 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium (CID 146012344) is 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium.
What is the SMILES notation for 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium?
The canonical SMILES for 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium is CCn1cnc2cc(-c3cc(OCC[NH+](C)C)c(C(N)=O)c4[nH]cnc34)ccc21.
What is the InChIKey of 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium?
The InChIKey is APQDNQILCACUFF-UHFFFAOYSA-O. The full InChI is InChI=1S/C21H24N6O2/c1-4-27-12-25-15-9-13(5-6-16(15)27)14-10-17(29-8-7-26(2)3)18(21(22)28)20-19(14)23-11-24-20/h5-6,9-12H,4,7-8H2,1-3H3,(H2,22,28)(H,23,24)/p+1.
What are the key properties of 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium?
2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium has a molecular weight of 393.47 g/mol, XLogP of 1.22, 7 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[4-carbamoyl-7-(1-ethylbenzimidazol-5-yl)-3H-benzimidazol-5-yl]oxy]ethyl-dimethylazanium is sourced from PubChem (CID 146012344), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).